Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Clinical trial NCT02255461 · TERMINATED
Trial details
- NCT number
- NCT02255461
- Sponsor
- Pediatric Brain Tumor Consortium
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-08
- Primary completion
- 2019-02-25
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.